Copyright
©The Author(s) 2018.
World J Hepatol. Nov 27, 2018; 10(11): 822-836
Published online Nov 27, 2018. doi: 10.4254/wjh.v10.i11.822
Published online Nov 27, 2018. doi: 10.4254/wjh.v10.i11.822
Table 1 Method adopted for whole complex organ acellularization techniques for different organisms
Organ | Acellularization agent | Perfusion method | Animal model | Reference |
Heart | SDS, PEG, Triton X-100, and enzyme-based protocols deoxycholic acid | Antegrade coronary perfusion | Rat | [98] |
Trypsin, EDTA, NaN3, Triton X-100, and deoxycholic acid | Retrograde aortic perfusion | Pig | [65] | |
Lung | 0.1% and 0.5% SDS | Antegrade pulmonary arterial perfusion | Rat | [63] |
CHAPS | Pulmonary artery and tracheal perfusion | Rat | [66] | |
Triton X-100 and sodium deoxycholate | Right ventricle and tracheal perfusion | Mouse | [99] | |
Liver | Triton X-100 plus 0.1% SDS | Portal vein perfusion | Rat | [100] |
SDS | Rat | [70] | ||
1% Triton X-100 and 0.1% ammonium hydroxide | Mouse, rat, ferret, rabbit and pig | [69] | ||
0.25% and 0.5% SDS | Pig | [101] | ||
Sodium citrate + SDS + Triton-X-100 | Hepatic artery perfusion | Rat | [74] | |
Kidney | 0.5, 3, 6, 10% Triton X-100, 5 mM | Renal artery perfusion | Rat | [71] |
calcium chloride, 5 mM magnesium sulfate, 1 M sodium chloride, DNase, and 4% sodium deoxycholate | Rat | [72] | ||
3% Triton X-100, DNase, and 4% SDS | ||||
1% SDS and 1% Triton X-100 | ||||
1% Triton X-100 and 0.1% ammonium hydroxide | Pig | [68] | ||
Heparin and antibiotic-containing physiological saline, 0.1-1.0% SDS, 0.1% Triton-X-100 and 0.0025% deoxyribonuclease 1 | Goat | [75] |
- Citation: Vishwakarma SK, Lakkireddy C, Bardia A, Paspala SAB, Tripura C, Habeeb MA, Khan AA. Bioengineered functional humanized livers: An emerging supportive modality to bridge the gap of organ transplantation for management of end-stage liver diseases. World J Hepatol 2018; 10(11): 822-836
- URL: https://www.wjgnet.com/1948-5182/full/v10/i11/822.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i11.822